Research Projects
Development of Adeno-Associated Vectors for In Vivo Renal Gene Therapy: Treatment of Autosomal Dominant Polycystic Kidney Disease Type II
Research Division
DNA and RNA Medicine Division
Research group
Renal Gene Therapy and Chimeric AAV Development
Project information
The project “Development of adeno-associated vectors for in vivo renal gene therapy: Treatment of autosomal dominant polycystic kidney disease type II” is a project of the Renal Gene Therapy and Chimeric AAV Development Group, which is part of the Gene Therapy Program for Rare Diseases.
Project PID2022-143327OB-I00 funded by:
- Convocation: Proyectos de Generación de Conocimiento 2022
- Reference: PID2022-143327OB-I00
- Start date: September 1, 2023
- End date: August 31, 2026
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us.